Personalized supervised exercise program for adults with breast or gynecologic cancer
Official title: Pilot Feasibility Trial for the Exercise Oncology Clinic in Breast and Gynecologic Oncology Patients
Run by University of Iowa · NCT07765927 · Data updated 2026-11-12
A small pilot study will test a supervised, personalized exercise program to see if it is safe, feasible, and acceptable for adults with a history of breast or gynecologic cancer.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | University of Iowa Academic / other |
| Locations | 1 site (Iowa City, Iowa) |
| Status | Recruiting |
| Started | August 3, 2026 |
| Main results expected | December 15, 2026 |
| Study ends | April 15, 2027 |
| Registry record updated | August 14, 2026 |
| Trial ID | NCT07765927 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with a confirmed breast or gynecologic cancer at any stage who are willing to participate and can provide informed consent.
✕Probably not a fit
Individuals with contraindications to exercise or who cannot complete required screenings may not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot trial enrolls up to 30 adults with breast or gynecologic cancer to participate in a structured exercise oncology clinic. The study aims to refine procedures for individualized exercise assessment and prescription within oncology care. It will generate preliminary data on feasibility, acceptability, and safety of integrating supervised exercise into routine cancer care.
Why it matters
Potential benefit: If successful, participants may experience a feasible and supportive exercise program that could improve well-being and physical function during and after cancer treatment.
How similar studies have gone: Previous work in exercise oncology suggests supervised programs can be feasible and safe in cancer populations, but this specific integrated clinic approach is exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Confirmed diagnosis of breast or gynecologic cancer (any stage) * Willingness to participate in the exercise oncology program and associated research procedures Ability to provide informed consent * Clearance to participate in exercise as determined by completion of the Physical Activity Readiness Questionnaire Plus (PAR-Q+) and any additional clinical screening as needed Exclusion Criteria: * Presence of absolute contraindications to exercise (e.g., unstable cardiovascular disease, acute illness, or other conditions that preclude safe participation in physical activity) * Determination by a referring or treating healthcare provider that the patient is not appropriate for exercise participation at the time of screening * Inability to complete required screening procedures, including the PAR-Q+
Where it's running
-
University of Iowa Health Care
Iowa City, Iowa, United States Recruiting
Study contacts
- Principal investigator: Jess Gorzelitz, PhD, MS — University of Iowa
- Study coordinator: Jess Gorzelitz, PhD, MS
- Email: jessica-gorzelitz@uiowa.edu
- Phone: (319) 467-0849
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High-precision detection of leftover cancer using a liquid-biopsy platform (SHERLOCK)
This project will test whether sensitive blood and other fluid tests for circulating tumor DNA can find leftover cancer (minimal residual disease) in adults treated with curative intent for breast, lung, melanoma, gynecologic, or genitourinary cancers.
-
Riluzole to prevent thinking and memory problems during chemotherapy
This pilot trial tests whether riluzole can prevent thinking and memory problems in adults with cancer receiving anthracycline- or platinum-based chemotherapy.
-
Web app for reporting side effects during radiation therapy
This project will try a web app that lets people receiving radiation for breast, gynecologic, or urologic cancers report symptoms and quality of life so clinicians can spot problems earlier.
-
7-day Via Shalva integrative retreat for breast and gynecologic cancer survivors
This pilot will try a 7-day integrative retreat called Via Shalva for breast and gynecologic cancer survivors to see if the program is feasible and whether participants show changes in symptoms, wearable physiological data, and biological markers versus matched controls.
-
Guided meditation during radiation for breast and gynecologic cancers
This project will test whether short guided meditations played during daily radiation can reduce anxiety for adults receiving radiation for breast or gynecologic cancer.
-
Florida ASCENT Program
This project will test whether combining the MyCarePulse EHR platform with ASCENT patient navigators helps adults with recent cancer diagnoses in Florida improve food security, diet quality, and confidence in healthy eating compared with standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.